Furthermore, elevated levels of H-FABP in blood samples after a stroke have been shown to originate from the CNS.[47] The possiblity to measure the presence of brain derived H-FABP in the blood may be, as suggested for S100B and GFAP, due to blood brain barrier damage or through the glymphatic system.[2]. This evidence concerns the gene FABP3 and stroke disorder.